Momentum Advisors’s Novo Nordisk NVO Stock Holding History

Momentum Advisors’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$575K	Sell	8,492 -122	-1%	-$7.15K	0.58%	34
2022 Q3	$429K	Buy	+8,614	New	+$461K	0.47%	40

Other funds holding NVO

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Momentum Advisors's NVO Position: Q4 2022 in Review

Momentum Advisors reduced its Novo Nordisk (NVO) stake by 1.4% in Q4 2022, selling an estimated $7.15K and leaving 8,492 shares worth $575K. The position accounts for 0.58% of the portfolio, ranked #34.

Momentum Advisors first reported a position in NVO in Q3 2022 and has held it in 2 quarters since. 1,049 funds tracked by Wall St. Rank hold NVO as of Q4 2022.

Momentum Advisors held 8,492 shares of Novo Nordisk worth $575K as of Q4 2022.
Momentum Advisors sold 122 Novo Nordisk shares in Q4 2022, an estimated $7.15K.
Novo Nordisk made up 0.58% of Momentum Advisors's portfolio in Q4 2022, its #34 holding.
Momentum Advisors first reported a position in Novo Nordisk in Q3 2022 and has held it in 2 quarters since.
1,049 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2022.

Based on Momentum Advisors's 13F filing for Q4 2022, filed 15 Feb 2023.